Abnormally high expression of INSL5 could activate JAK1‐STAT5 signaling to induce aerobic glycolysis to promote NPC tumor growth and invasion dependent on the INSL5 receptor GPCR142. The gene discussed is RXFP4; the disease is nasopharyngeal carcinoma.